SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001193125-19-173721
Filing Date
2019-06-14
Accepted
2019-06-14 16:31:00
Documents
2
Effectiveness Date
2019-06-14

Document Format Files

Seq Description Document Type Size
1 DEFA14A d764971ddefa14a.htm DEFA14A 42265
2 GRAPHIC g764971g0614232333983.jpg GRAPHIC 3293
  Complete submission text file 0001193125-19-173721.txt   48043
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

IRS No.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-36274 | Film No.: 19899308
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences